Hepatectomy Donor for living donor liver transplantation Hepatectomy
Conditions
Interventions
Sponsors
Urade Takeshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Patients who are 20 years of age or older at the time consent is obtained (2) Patients who meet any of the following conditions; Hepatectomy is the first-line treatment for hepatobiliary diseases, Donors undergoing partial hepatectomy for living donor liver transplantation (3) Patients who need to undergo cholecystectomy as a liver resection procedure (4) Patients requiring resection of more than one area for hepatectomy (5) Patients who have been fully informed of the study and have given their written consent prior to enrollment in the study
Exclusion criteria
Exclusion criteria: (1) Patients with a history of hypersensitivity to sonazoid or urographin components (2) Patients allergic to eggs or egg products (3) Patients with serious thyroid disease (4) Patients with preoperative complications such as cholecystitis or cholangitis (5) Patients participating in other clinical interventional studies (6) Patients who are judged to be inappropriate for this study by the principal investigator and subinvestigators (hereafter referred to as "principal investigators") for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time for intraoperative cholangiography | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction with the cholangiography method by means of a questionnaire to the surgeons Accuracy of cholangiography Perioperative incidence of biliary tract-related complications (bile leak, bile duct stricture) Comparison of accuracy of cholangiography method with another method in case of cholangiography failure The safety in off-label use of sonazoid Mortality rate, incidence of complications, blood loss, blood transfusion, operation time, postoperative hospital stay | — |
Contacts
Public ContactTakeshi Urade
Kobe University Hospital
Outcome results
None listed